ArticleMolecular and clinical oncology2014

Efficacy of tyrosine kinase inhibitors in non-small-cell lung cancer patients undergoing dose reduction and those with a low body surface area.

Shinya Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.